Drug Class - Beta Blockers

Front 1

Three groups of beta blockers?

Back 1

beta blockers (nonselective)
beta blockers (selective)
ophthalmic beta blockers

Front 2

Nine nonselective beta blockers?

Back 2

carteolol
carvedilol
labetalol
nadolol
penbutolol
pindolol
propranolol
solatol
timolol

Front 3

Six selective beta blockers?

Back 3

acebutolol
atenolol
betaxolol
bisoprolol
esmolol
metoprolol

Front 4

Six ophthalmic beta blockers?

Back 4

betaxolol
carteoolol
levobetaxolol
levobunolol
metipranolol
timolol

Front 5

Name 8 uses for beta blockers?
match ghm

Back 5

angina pectoris
tachyarrhthmias
hypertrophic subaortic
stenosis
migraine headache
(prophylaxis)
MI (prevention)
glaucoma ((ophthalmic use)
CHF (carvedilol and sustained
release metoprolol only)
hyperthyroidism (management
of symptoms)

Front 6

Beta blockers compete with _______ (________) neurotransmitters (epinephrine and norepinephrine) for adrenergic receptor sites.

Back 6

adrenergic (sympathetic)

Front 7

Beta1-adrenergic receptor sites are located chiefly in the ____ where stimulation results in (increased, decreased) heart rate, contractility, and AV conduction.

Back 7

heart
increased

Front 8

Beta2-adrenergic receptors are found mainly in ______ and _____ smooth muscle and the uterus.

Back 8

bronchial
vascular

Front 9

Stimulation of beta2-adrenergic receptors produces?
(3)

Back 9

vasodilation
bronchodilation
uterine relaxation

Front 10

Blockage of beta2-adrenergic receptors ______ the effects of neurotransmitters.

Back 10

antagonizes

Front 11

Beta blockers may be relatively SELECTIVE for beta1-adrenergic receptors.
Five beta blockers that do this are?

Back 11

acebutolol
atenolol
betaxolol
esmolol
metroprolol

Front 12

Beta blockers may be relatively NONSELECTIVE for blocking both beta1- and beta2-adrenergic receptors. Ten beta blockers that block both are?

Back 12

carteolol
carvedilol
labetalol
levobunolol
nadolol
penbutolol
pindolol
propranolol
sotalol
timolol

(carvedilol and labetalol have additional alpha-adrenergic blocking properties

Front 13

Which four agents possess intrinsic sympathomimetic action(ISA) that may result in less bradycardia than other agents?

Back 13

acebutolol
carvedilol
penbutolol
pindolol

Front 14

Ophthalmic beta blockers decrease production of ____ ____.

Back 14

aqueous humor

Front 15

Name 5 contraindications?

Back 15

uncompensated CHF (most beta
blockers)
acute bronchospasm
some forms of valvular heart
disease
bradyarrhythmias
heart block

Front 16

Use cautiously in pregnant and lactating women (may cause fetal _______ and ______).

Back 16

bradycardia
hypoglycemia

Front 17

Use cautiously in any form of _____ disease or underlying compensated CHF (most agents).

Back 17

lung

Front 18

Use with caution in diabetics and patients with severe ____ disease.

Back 18

liver

Front 19

Beta blockers should not be abruptly discontinued in patients with _____ disease.

Back 19

cardiovascular

Front 20

May cause additive myocardial depression and ______ when used with other agents having these effects (digoxin and some antiarrhythmics).

Back 20

bradycardia

Front 21

May antagonize the therapeutic effects of _____

Back 21

bronchodilators

Front 22

May alter the requirements for _____ or hypoglycemic agents in diabetics.

Back 22

insulin

Front 23

______ may decrease the metabolism and increase the effects of some beta blockers.

Back 23

cimetidine

Front 24

Three major conditions to monitor for when on beta blockers are?

Back 24

angina (assess frequency and
severity of chest pain)
migraines (assess frequency
and severity of migraines)
CHF

Front 25

Assessing patient while on beta blockers includes?

Back 25

monitor blood pressure and
pulse frequently during
dosage adjustment and
periodically throughout
therapy
monitor I & O ratios
monitor daily weight
look for signs and symptoms
of CHF (dyspnea, rales/
crackles, weight gain,
peripheral edema, jugular
venous distention)

Front 26

What are the signs of CHF?

Back 26

dyspnea
rales/crackles
weight gain
peripheral edema
jugular
venous distention

Front 27

List 3 potential nursing diagnoses.

Back 27

Tissue perfusion, ineffective

Knowledge, deficient, related to disease processes and medication regimen

Noncompliance

Front 28

IMPLEMENTATION:
Take ____ pulse prior to administering. If heart rate is less than ____ bpm or if _____ occur, hold medication and notify hcp

Back 28

apical
50
arrhythmias

Front 29

Many beta blockers are available in ______ products to enhance compliance.

Back 29

combination

Front 30

Instruct patient to continue taking medication, even if feeling well. Abrupt withdrawal may cause life-threatening _____, _____, or myocardial _____. Medication controls but does not cure hypertension.

Back 30

arrhythmias
hypertension
ischemia

Front 31

Encourage patient to comply with additional interventions for hypertension which include?

Back 31

weight reduction
low-sodium diet
regular exercise
smoking cessation
moderation of alcohol
consumption
stress management

Front 32

Instruct patient and family on proper technique for monitoring _____ _____. Advise them to check blood pressure weekly and report significant changes to hcp.

Back 32

blood pressure

Front 33

Caution patient to make position changes slowly to minimize ____ ____. Advise patient that exercising or ____ weather may enhance hypotensive effects.

Back 33

orthostatic hypotension
hot

Front 34

Advise patient to consult hcp before taking any ____ medications or herbal-alternative therapies, esp ___ remedies.

Back 34

OTC
cold

Front 35

Caution patient that these medications may cause ____ sensitivity to cold.

Back 35

increased

Front 36

Diabetics should monitor blood glucose closely, esp if which 4 symptoms occur?

Back 36

weakness
malaise
irritability
fatigue

Front 37

Advise patient to advise hcp of medication regimen prior to treatment or _____.

Back 37

surgery

Front 38

Advise patient to carry id describing disease process and medication regimen at all times.

Back 38

okay

Front 39

Emphasize the importance of follow-up exams to monitor progress.

Back 39

okay

Front 40

Instruct patient in correct technique for administration of _____ preparations.

Back 40

ophthalmic

Front 41

EVALUATION:
Effectiveness of therapy can be demonstrated by?
Decrease in 1_____ ______
Decrease in frequency and
severity of 2_____ ____.
Control of 3______.
Prevention of myocardial 4______, 5 ____ headaches, and tremors.
Lowering of 6______ pressure.

Back 41

1 blood pressure
2 anginal attacks
3 arrhythmias
4 infarction
5 migraine
6 intraocular